Cite
Updated DPYDHapB3 haplotype structure and implications for pharmacogenomic testing.
MLA
Turner, Amy J., et al. “Updated DPYDHapB3 Haplotype Structure and Implications for Pharmacogenomic Testing.” CTS: Clinical & Translational Science, vol. 17, no. 1, Jan. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1111/cts.13699.
APA
Turner, A. J., Haidar, C. E., Yang, W., Boone, E. C., Offer, S. M., Empey, P. E., Haddad, A., Tahir, S., Scharer, G., Broeckel, U., & Gaedigk, A. (2024). Updated DPYDHapB3 haplotype structure and implications for pharmacogenomic testing. CTS: Clinical & Translational Science, 17(1), 1–7. https://doi.org/10.1111/cts.13699
Chicago
Turner, Amy J., Cyrine E. Haidar, Wenjian Yang, Erin C. Boone, Steven M. Offer, Philip E. Empey, Andrew Haddad, et al. 2024. “Updated DPYDHapB3 Haplotype Structure and Implications for Pharmacogenomic Testing.” CTS: Clinical & Translational Science 17 (1): 1–7. doi:10.1111/cts.13699.